Medical Curriculum Technologies is categorized under Health Services in Orlando, FL and active since 2009.
Medical Curriculum Technologies was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Fred B Clayton at the company’s single location by writing to 2710 Discovery Drive # 100, Orlando, Florida FL 32826 or by phoning (407) 704-6274. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medical Curriculum Technologies |
| Contact Person: | Fred B Clayton |
| Address: | 2710 Discovery Drive # 100, Orlando, Florida 32826 |
| Phone Number: | (407) 704-6274 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Medical Curriculum Technologies was started in 2009 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Fred B Clayton for inquiries that concern Medical Curriculum Technologies by calling the company number (407) 704-6274, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Curriculum Technologies can be found at the coordinates 28.585504,-81.192427 as well as the street address 2710 Discovery Drive # 100 in Orlando, Florida 32826.
For its online presence, you may visit Medical Curriculum Technologies’s website at and engage with its social media outlets through on Twitter and on Facebook.